The Iceland-based generic pharmaceuticals company, Actavis, announced last week that it has entered into a binding letter of intent with QRxPharma to launch MoxDuo® IR in the United States. The product launch in the U.S. is expected in the third quarter of 2012. Claudio Albrecht, CEO of Actavis said, “This partnership ... Read More...
Recent Posts
- The Engine Listed Among the Ten Best Digital Marketing Agencies in Europe January 7, 2021
- Icelandic tarot deck wins International Tarot Foundation prizes December 7, 2020
- Iceland Aviation Academy becomes market leader in the Nordic region November 30, 2020
- Valka introduces a revolutionary salmon cutter November 26, 2020
- Comply by TBI – The next generation of VAT Compliance software November 25, 2020
Submit Your Press Release at eNewsWire
eNewsWire is an online press release service offering both free and paid distribution. eNewWire distributes business, organisational and personal news and press releases using the Internet. Submit your press release here.